Effect of Mindful Eating on Weight Management in Breast Cancer Survivors
Effect of a Mindful Eating Intervention on Weight Management in Overweight and Obese Postmenopausal Breast Cancer Survivors
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Non applicabile
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Postmenopausal female
- Breast cancer survivor (in remission)
- Completed cancer treatment at the time of study enrollment
- Body Mass Index (BMI) equal or greater than 25 kg/m²
Exclusion Criteria:
- None.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Mindful eating intervention
The mindful eating intervention was taught by a mindfulness-based stress reduction instructor certified by the Center of Mindfulness at the University of Massachusetts Medical School.
|
A Mindful Eating Workshop™ workbook was used for standardization and reproducibility of these sessions.
The group sessions were focused on teaching applied strategies to consume food with intention and attention and aimed at improving emotional relationships with food.
Intervention sessions were held once a week in the evening for 2 hours per session over 8 weeks.
The intervention was delivered in a large conference room on the University of Georgia campus.
Participants were required to attend seven out of eight sessions.
If participants missed a session, they met with the instructor 30 minutes before the beginning of the following week's session to receive individual instruction on content of the missed session.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Body Mass Index
Lasso di tempo: Change measured between weeks 1 and 12
|
At the baseline and follow-up visits, trained study staff measured participants' weight and height using a standardized protocol.
Height (measured by a stadiometer to the nearest 0.1 cm) and weight (measured by a scale to the nearest 0.1 kg) was used to calculate BMI (weight in kg divided by height in m²).
|
Change measured between weeks 1 and 12
|
|
Blood Pressure
Lasso di tempo: Change measured between weeks 1 and 12
|
At the baseline and follow-up visits, trained study staff measured participants' systolic/diastolic blood pressure using a standardized protocol to the nearest mmHg.
In order to ensure reliability, all measurements were taken 3 times and average values were used for analyses.
|
Change measured between weeks 1 and 12
|
|
Waste and Hip Circumference
Lasso di tempo: Change measured between weeks 1 and 12
|
At the baseline and follow-up visits, trained study staff measured participants' waist and hip circumference by tape measure to the nearest 0.1 centimeter.
|
Change measured between weeks 1 and 12
|
|
Body Fat Percentage
Lasso di tempo: Change measured between weeks 1 and 12
|
At the baseline and follow-up visits, trained study staff measured participants' body fat percentage using a bioelectrical impedance analyzer (BIA).
|
Change measured between weeks 1 and 12
|
|
Feasibility of Conducting the Intervention
Lasso di tempo: Measured at week 12
|
Feasibility was assessed by tracking participant accrual and retention rates.
|
Measured at week 12
|
|
Acceptability of the Intervention
Lasso di tempo: Measured at week 12
|
To measure acceptability, participants were asked to complete a 5-question feedback survey to evaluate the mindful eating intervention at the follow-up study visit.
Specifically, the open-ended survey questions asked participants about (1) their experience with intervention, (2) how the intervention affected diet and exercise management, (3) positive aspects about the intervention, (4) negative aspects about the intervention, and (5) suggested changes to the intervention.
Qualitative data analysis techniques were used to identify themes within the data.
|
Measured at week 12
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mindful Eating Measures
Lasso di tempo: Change measured between weeks 1 and 12
|
Changes in mindfulness resulting from the intervention were measured using the validated Mindful Attention Awareness Scale (MAAS).
The MAAS questionnaire is a 15-item scale that was designed to assess mindfulness and receptive awareness throughout an individual's daily life.
Scores from the MAAS range from 1 to 6, with higher scores associated with higher mindfulness.
The MAAS was validated for use in cancer populations against the Profile of Mood States (POMS) scale that is widely used in clinical settings.
Higher MAAS scores were significantly correlated with lower POMS scores, further confirming the construct validity of the MAAS questionnaire for assessing mindfulness in cancer populations.
The questionnaire was self-administered to the participants pre and post intervention.
|
Change measured between weeks 1 and 12
|
Altre misure di risultato
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Nutritional Intake
Lasso di tempo: Change measured between weeks 1 and 12
|
Habitual nutritional intake was measured using an electronic version of the Block Food Frequency Questionnaire, a 127-item food and beverage recall instrument referencing the consumption over the past month.
Dietary intake data was describes as daily energy consumption (kcal), consumption of macronutrients (fat, protein, carbohydrate; grams/day), and intake of sweets (% of daily intake) to compare intake before intervention start with intake during the intervention.
|
Change measured between weeks 1 and 12
|
|
Physical Activity
Lasso di tempo: Change measured between weeks 1 and 12
|
Participants' physical activity levels (average daily steps; moderate-to-vigorous physical activity (MVPA) minutes) were tracked throughout the study period using FitBit® Flex accelerometers.
Total daily steps and MVPA minutes were averaged for the first and the last week of the intervention to examine changes.
|
Change measured between weeks 1 and 12
|
Collaboratori e investigatori
Sponsor
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- STUDY00002818
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .